Assembly Biosciences, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Assembly Biosciences, Inc. (ASMB) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $378.80 million as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2021-02-25
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $378.80M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $297.60M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $209.20M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $153.20M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2020-12-31 | $378.80M 10-K · filed 2021-02-25 |
| 2019-12-31 | $297.60M 10-K · filed 2020-03-04 |
| 2018-12-31 | $209.20M 10-K · filed 2019-02-28 |
| 2017-12-31 | $153.20M 10-K · filed 2018-03-08 |
| 2016-12-31 | $146.50M 10-K · filed 2017-03-02 |
| 2015-12-31 | $105.00M 10-K · filed 2016-03-11 |
| 2014-12-31 | $86.55M 10-K · filed 2015-03-16 |
| 2013-12-31 | $73.00M 10-K · filed 2014-03-31 |
| 2012-12-31 | $5.50M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |